Pairing data-driven clinical-molecular insights with biological validation to identify relevant drug targets and confirm ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

Dr. John Beeler, BPGbio, discusses why investing in biology is essential for AI-driven drug discovery and for building a more ...

A Hong Kong University of Science and Technology (HKUST) research team has developed a catalytic enantioselective type II ...

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows ...

Radyus Research, a U.S.-based drug development organization, and Eurofins CDMO Alphora, a Canadian contract development and ...

According to brokerage Jefferies, the average drug development cycle spans 8 to 10 years, with success rates below 10% and ...

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

While all groups have demonstrated an inspiring level of dedication and passion, I have always been moved by patients’ ...

Molecular Health & Axxam ink partnership to bolster discovery of innovative targets indrug development: Milan, Italy Thursday, June 5, 2025, 10:00 Hrs [IST] Axxam S.p.A., a premie ...

The partnership will integrate Molecular Health’s digital drug development platform into Axxam's integrated early drug ...